Purpose To report the natural history of untreated neovascular age-related macular
degeneration (nAMD) regarding subsequent macular atrophy. Design Prospective cohort …

Purpose To identify the development and progression of macular retinal pigment epithelial
atrophy in eyes with neovascular age-related macular degeneration (AMD) and to correlate …

Purpose To compare the incidence and progression of macular atrophy (MA) in eyes with
neovascular age-related macular degeneration (nAMD) treated with anti–vascular …

Background To assess the prevalence and characteristics associated with macular atrophy
(MA) in eyes with neovascular age-related macular degeneration (nAMD) treated with …

Purpose To report and compare 10-year treatment outcomes of vascular endothelial growth
factor (VEGF) inhibitors for neovascular age-related macular degeneration (nAMD) from …

Purpose Although intravitreal anti-vascular endothelial growth factor (VEGF) injection has
become the mainstay treatment for neovascular age-related macular degeneration (nAMD) …

Purpose To assess differences in the progression of macular atrophy (MA) between
neovascular age‐related macular degeneration (AMD) subtypes and to identify the risk …

Purpose To report on the development and progression of macular atrophy (MA) and its
relationship with morphologic and functional measures in study and fellow eyes in the …

Importance The Age-Related Eye Disease Study age-related macular degeneration
(AREDS AMD) scale is designed to classify AMD severity. The present cohort study explored …

We investigated the characteristics of neovascular age-related macular degeneration
(AMD), which rarely recurs after initial remission. This study retrospectively analyzed 392 …